Based on Research Developed in the Clinic
Xaga Surgical's research and product development have been the result of a collaborative effort by a diverse and interdisciplinary team. Encompassed by experts in infection control, urology, surgery, pathology, intensive care, medical technology, engineering, prototyping, research, as well as partnerships with several Swedish and international companies it is a true team effort. The orchestrator of this collaborative endeavor has been Andreas Forsvall at Lund University and the final results of our efforts are the products developed by Xaga Surgical.
Xaga Surgical´s primary goal has been to transition from identifying problems to delivering effective solutions, which has culminated in our first breakthrough development - the Forsvall Biopsy System. The scientific foundation underpinning these advancements are being explored further with several new products in development . We have several ongoing trials, stay updated by signing up for our Newsletter!
The Forsvall biopsy needle – a novel way of addressing infections in transrectal prostate
Short video abstract of the scientific background of the Forsvall Biopsy System. Winner of best Abstract at the International Prostate Cancer Update in Vail, USA Jan 2023.
Can a modified biopsy needle reduce infections and improve diagnostic accuracy
Short video abstract and demonstration of the Forsvall Biopsy Needle movement in simulated target biopsy, as well as a planned large trial.Please note that needle deviation is dependent of tissue properties and distance to target, the video is just a demonstration.
Presented at the International Prostate Cancer Update in Vail, USA Jan 2023
Biopsy Needle Design Matters
Short video presentation of the winner of Best paper at Engineering & Urology Society, AUA Annual Meeting 2025, Las Vegas.
The deadly spiral in Antibiotic Resistance
Antibiotic resistance is a global crisis, with bacteria and microorganisms evolving to resist antibiotic treatment. Overuse and misuse of antibiotics in human medicine, agriculture, and livestock accelerate this problem. Hospital-acquired infections, often requiring antibiotic treatment, worsen the issue. These infections further envelope already antibiotic-resistant bacteria. Treating such infections becomes costlier and more challenging, leading to prolonged illness and higher mortality rates. A deadly spiral placing antibiotic resistance as one of the top 10 threats to humanity. To tackle this threat, responsible antibiotic use, new antibiotics, and infection prevention are vital.
Xaga Surgical contributes by the most vital step in infection prevention- source control. By developing safer needles we aim to prevent infections and reduce the need to treat already resistant bacteria, breaking the deadly spiral.
Publications
1) Forsvall A, Fisher J, Cardoso JFP, Wagenius M, Tverring J, Nilson B, Dahlin A, Bratt O, Linder A, Mohanty T.
Evaluation of the Forsvall biopsy needle in an ex vivo model of transrectal prostate biopsy - a novel needle design with the objective to reduce the risk of post-biopsy infection. Scand J Urol. 2021 Jun;55(3):227-234. doi: 10.1080/21681805.2021.1921023. Epub 2021 May 17. PMID: 33999753.
2) Forsvall A, Fisher J, Wagenius M, Broman C, Korkocic D, Bratt O, Linder A.
Prostate biopsy quality and patient experience with the novel Forsvall biopsy needle - a randomized controlled non-inferiority trial. Scand J Urol. 2021 Jun;55(3):235-241. doi: 10.1080/21681805.2021.1921024. Epub 2021 May 17. PMID: 33999764.